Regulation - Gilead Sciences, idelalisib

Filter

Current filters:

Gilead Sciencesidelalisib

Popular Filters

Gilead files for US approval of iNHL drug candidate

12-09-2013

US biotech major Gilead Sciences (Nasdaq: GILD), best known for its prowess in antivirals (HIV and hepatitis…

BiotechnologyGilead SciencesidelalisibNorth AmericaOncologyRegulation

Back to top